Your browser doesn't support javascript.
loading
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF.
Di Tacchio, Mariangela; Macas, Jadranka; Weissenberger, Jakob; Sommer, Kathleen; Bähr, Oliver; Steinbach, Joachim P; Senft, Christian; Seifert, Volker; Glas, Martin; Herrlinger, Ulrich; Krex, Dietmar; Meinhardt, Matthias; Weyerbrock, Astrid; Timmer, Marco; Goldbrunner, Roland; Deckert, Martina; Scheel, Andreas H; Büttner, Reinhard; Grauer, Oliver M; Schittenhelm, Jens; Tabatabai, Ghazaleh; Harter, Patrick N; Günther, Stefan; Devraj, Kavi; Plate, Karl H; Reiss, Yvonne.
Afiliação
  • Di Tacchio M; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt, Germany.
  • Macas J; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Weissenberger J; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sommer K; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt, Germany.
  • Bähr O; Frankfurt Cancer Institute, Frankfurt, Germany.
  • Steinbach JP; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt, Germany.
  • Senft C; Frankfurt Cancer Institute, Frankfurt, Germany.
  • Seifert V; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt, Germany.
  • Glas M; Frankfurt Cancer Institute, Frankfurt, Germany.
  • Herrlinger U; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Krex D; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Meinhardt M; Frankfurt Cancer Institute, Frankfurt, Germany.
  • Weyerbrock A; Senckenberg Institute of Neurooncology, University Hospital, Goethe University, Frankfurt, Germany.
  • Timmer M; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Goldbrunner R; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Deckert M; Frankfurt Cancer Institute, Frankfurt, Germany.
  • Scheel AH; Senckenberg Institute of Neurooncology, University Hospital, Goethe University, Frankfurt, Germany.
  • Büttner R; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Grauer OM; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schittenhelm J; Department of Neurosurgery, University Hospital, Goethe University, Frankfurt, Germany.
  • Tabatabai G; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Harter PN; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Günther S; Department of Neurosurgery, University Hospital, Goethe University, Frankfurt, Germany.
  • Devraj K; Department of Neurology, Division of Clinical Neurooncology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Plate KH; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Reiss Y; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Cancer Immunol Res ; 7(12): 1910-1927, 2019 Dec.
Article em En | MEDLINE | ID: mdl-31597643
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Inibidores da Angiogênese / Angiopoietina-2 / Fator A de Crescimento do Endotélio Vascular / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Inibidores da Angiogênese / Angiopoietina-2 / Fator A de Crescimento do Endotélio Vascular / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article